|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 1. | EM Vaughan Williams | ||
| A classification of antiarrhythmic actions reassessed after a decade of new drugs | |||
|---|---|---|---|
|
J Clin Pharmacol Apr 01, 1984; 24: 129-147.
(In "Articles") |
|||
| 2. | A Van Hecken, JI Schwartz, M Depre, I De Lepeleire, A Dallob, W Tanaka, K Wynants, A Buntinx, J Arnout, PH Wong, DL Ebel, BJ Gertz, PJ De Schepper | ||
| Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers | |||
|
J Clin Pharmacol Oct 01, 2000; 40: 1109-1120.
(In "Articles") |
|||
| 3. | K Venkatakrishnan, LL Von Moltke, DJ Greenblatt | ||
| Human drug metabolism and the cytochromes P450: application and relevance of in vitro models | |||
|
J Clin Pharmacol Nov 01, 2001; 41: 1149-1179.
(In "Articles") |
|||
| 4. | PD Kroboth, FS Salek, AL Pittenger, TJ Fabian, RF Frye | ||
| DHEA and DHEA-S: a review | |||
|
J Clin Pharmacol Apr 01, 1999; 39: 327-348.
(In "Articles") |
|||
| 5. | Jang-Ik Lee, Gilbert J. Burckart | ||
| Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target | |||
|
J Clin Pharmacol Nov 01, 1998; 38: 981-993.
(In "Journal Article") |
|||
| [Next 5 Articles] | |||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |